MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy
Authors:
Open Access
- 18 November 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (64) , 107500-107512
Abstract
MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagyKeywords
This publication has 50 references indexed in Scilit:
- miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2Oncology Reports, 2013
- Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcomaAutophagy, 2012
- Chemotherapy and autophagy-mediated cell death in pancreatic cancer cellsPancreatology, 2012
- Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanismCell Death & Disease, 2011
- Dysregulation of miR-15a and miR-214 in human pancreatic cancerJournal of Hematology & Oncology, 2010
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDFCancer Research, 2010
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating CellsPLOS ONE, 2009
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic CancerBritish Journal of Cancer, 2009
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer CellsCancer Research, 2009
- MicroRNA—implications for cancerVirchows Archiv, 2007